 Carolyn Welsh
Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchiolitis Obliterans | 2 | 2015 | 66 | 0.800 |
Why?
| | Societies, Medical | 2 | 2015 | 703 | 0.550 |
Why?
| | Lung Diseases | 4 | 2024 | 718 | 0.460 |
Why?
| | Lung Transplantation | 1 | 2015 | 263 | 0.430 |
Why?
| | Pulmonary Medicine | 2 | 2014 | 85 | 0.320 |
Why?
| | Hypercapnia | 1 | 2007 | 50 | 0.310 |
Why?
| | Venous Thrombosis | 2 | 2007 | 147 | 0.310 |
Why?
| | Systems Biology | 1 | 2007 | 57 | 0.290 |
Why?
| | Deoxycytidine | 1 | 2007 | 136 | 0.280 |
Why?
| | Palliative Care | 2 | 2024 | 629 | 0.270 |
Why?
| | Syphilis, Cutaneous | 1 | 2004 | 2 | 0.250 |
Why?
| | Endotoxins | 4 | 1993 | 234 | 0.250 |
Why?
| | Treponema pallidum | 1 | 2004 | 7 | 0.250 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2007 | 231 | 0.240 |
Why?
| | Pneumonia | 2 | 2007 | 592 | 0.230 |
Why?
| | Patient Care Team | 2 | 2024 | 521 | 0.200 |
Why?
| | Physician's Role | 1 | 2003 | 200 | 0.190 |
Why?
| | Pentoxifylline | 2 | 1991 | 22 | 0.180 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 1390 | 0.170 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2024 | 1137 | 0.170 |
Why?
| | Heart Failure | 2 | 2024 | 1969 | 0.170 |
Why?
| | Lung Diseases, Interstitial | 2 | 2024 | 464 | 0.160 |
Why?
| | Telemedicine | 1 | 2024 | 664 | 0.130 |
Why?
| | Neutrophils | 4 | 1991 | 1233 | 0.130 |
Why?
| | Prazosin | 1 | 2015 | 22 | 0.130 |
Why?
| | Dreams | 1 | 2015 | 11 | 0.130 |
Why?
| | Capillary Permeability | 4 | 1993 | 140 | 0.130 |
Why?
| | Pneumonia, Mycoplasma | 1 | 1995 | 33 | 0.130 |
Why?
| | Syndrome | 1 | 2015 | 344 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1244 | 0.120 |
Why?
| | Pulmonary Ventilation | 1 | 1993 | 71 | 0.110 |
Why?
| | Quality of Life | 2 | 2024 | 2366 | 0.110 |
Why?
| | Pulmonary Embolism | 3 | 1999 | 183 | 0.110 |
Why?
| | Salmonella enteritidis | 2 | 1989 | 16 | 0.110 |
Why?
| | Acclimatization | 1 | 1993 | 135 | 0.100 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 241 | 0.100 |
Why?
| | Respiratory Insufficiency | 1 | 1995 | 290 | 0.100 |
Why?
| | Antibiotics, Antitubercular | 1 | 1991 | 35 | 0.100 |
Why?
| | Pulmonary Circulation | 2 | 1993 | 424 | 0.100 |
Why?
| | Gastrectomy | 1 | 1991 | 82 | 0.090 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1991 | 112 | 0.090 |
Why?
| | Humans | 19 | 2024 | 118974 | 0.090 |
Why?
| | Lung | 6 | 1999 | 3664 | 0.090 |
Why?
| | Altitude | 1 | 1993 | 422 | 0.090 |
Why?
| | Theobromine | 1 | 1988 | 2 | 0.090 |
Why?
| | Pulmonary Artery | 2 | 1993 | 1063 | 0.080 |
Why?
| | Aging | 1 | 1998 | 1670 | 0.080 |
Why?
| | Mycobacterium tuberculosis | 1 | 1991 | 266 | 0.080 |
Why?
| | Blood Proteins | 2 | 1993 | 248 | 0.080 |
Why?
| | Diagnosis | 1 | 2007 | 10 | 0.080 |
Why?
| | Carboplatin | 1 | 2007 | 142 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1440 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 3 | 2004 | 2436 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2015 | 765 | 0.070 |
Why?
| | Male | 13 | 2024 | 57801 | 0.070 |
Why?
| | Single-Blind Method | 2 | 2024 | 269 | 0.070 |
Why?
| | Dyspnea | 1 | 2007 | 201 | 0.070 |
Why?
| | Aged | 7 | 2024 | 19657 | 0.070 |
Why?
| | Pulmonary Edema | 3 | 1993 | 125 | 0.070 |
Why?
| | Asthma | 2 | 2014 | 2158 | 0.070 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2007 | 211 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 1991 | 907 | 0.060 |
Why?
| | Risk | 1 | 2007 | 853 | 0.060 |
Why?
| | Social Workers | 1 | 2024 | 28 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2015 | 2235 | 0.060 |
Why?
| | Biopsy, Needle | 1 | 2004 | 190 | 0.060 |
Why?
| | Activated Protein C Resistance | 1 | 2003 | 2 | 0.060 |
Why?
| | Radiography, Thoracic | 1 | 2004 | 164 | 0.060 |
Why?
| | Medical Laboratory Science | 1 | 2003 | 7 | 0.060 |
Why?
| | Factor V | 1 | 2003 | 23 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2007 | 2674 | 0.060 |
Why?
| | Obesity | 2 | 2007 | 2746 | 0.060 |
Why?
| | Information Systems | 1 | 2003 | 66 | 0.050 |
Why?
| | Nurse's Role | 1 | 2024 | 102 | 0.050 |
Why?
| | Patient Readmission | 1 | 2007 | 634 | 0.050 |
Why?
| | Certification | 1 | 2003 | 99 | 0.050 |
Why?
| | Workload | 1 | 2003 | 128 | 0.050 |
Why?
| | Age Distribution | 1 | 2003 | 362 | 0.050 |
Why?
| | Sex Distribution | 1 | 2003 | 351 | 0.050 |
Why?
| | Canada | 1 | 2003 | 340 | 0.050 |
Why?
| | Nurses | 1 | 2024 | 142 | 0.050 |
Why?
| | Employment | 1 | 2003 | 135 | 0.050 |
Why?
| | Terminal Care | 1 | 2024 | 187 | 0.050 |
Why?
| | Hypoxia | 1 | 2007 | 963 | 0.050 |
Why?
| | Middle Aged | 7 | 2004 | 27617 | 0.050 |
Why?
| | Needs Assessment | 1 | 2003 | 327 | 0.050 |
Why?
| | Respiration, Artificial | 1 | 2004 | 545 | 0.050 |
Why?
| | Ambulatory Care | 1 | 2024 | 482 | 0.050 |
Why?
| | Dogs | 3 | 1993 | 371 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1691 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2004 | 4596 | 0.040 |
Why?
| | Adult | 6 | 2024 | 31512 | 0.040 |
Why?
| | Snoring | 1 | 1998 | 11 | 0.040 |
Why?
| | Respiratory Muscles | 1 | 1998 | 36 | 0.040 |
Why?
| | Lung Diseases, Obstructive | 1 | 1998 | 44 | 0.040 |
Why?
| | Pulmonary Gas Exchange | 1 | 1998 | 117 | 0.040 |
Why?
| | Respiratory Mechanics | 1 | 1998 | 60 | 0.040 |
Why?
| | Carcinoma, Small Cell | 1 | 1998 | 158 | 0.040 |
Why?
| | Ventilation-Perfusion Ratio | 2 | 1998 | 11 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 1998 | 80 | 0.040 |
Why?
| | Female | 8 | 2024 | 61565 | 0.040 |
Why?
| | Chronic Disease | 2 | 2019 | 1636 | 0.030 |
Why?
| | Advance Care Planning | 1 | 2019 | 191 | 0.030 |
Why?
| | Tuberculosis | 1 | 1998 | 240 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2003 | 992 | 0.030 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 2015 | 16 | 0.030 |
Why?
| | Physicians | 1 | 2003 | 794 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2003 | 2275 | 0.030 |
Why?
| | Maximal Midexpiratory Flow Rate | 1 | 1993 | 4 | 0.030 |
Why?
| | Sleep | 1 | 1998 | 660 | 0.030 |
Why?
| | Spirometry | 1 | 1993 | 263 | 0.030 |
Why?
| | Vital Capacity | 1 | 1993 | 260 | 0.030 |
Why?
| | Time Factors | 2 | 2015 | 6412 | 0.030 |
Why?
| | Proteins | 2 | 1989 | 938 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 1993 | 520 | 0.030 |
Why?
| | Coronary Vessels | 1 | 1993 | 233 | 0.030 |
Why?
| | Chromium Radioisotopes | 1 | 1991 | 3 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2003 | 4708 | 0.020 |
Why?
| | Drug Resistance, Microbial | 1 | 1991 | 67 | 0.020 |
Why?
| | Permeability | 1 | 1991 | 156 | 0.020 |
Why?
| | Prognosis | 1 | 1998 | 3443 | 0.020 |
Why?
| | Albumins | 1 | 1991 | 100 | 0.020 |
Why?
| | Vascular Surgical Procedures | 1 | 1993 | 262 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 1991 | 104 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 1998 | 968 | 0.020 |
Why?
| | Radiography | 1 | 1993 | 861 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1991 | 242 | 0.020 |
Why?
| | Antitubercular Agents | 1 | 1991 | 163 | 0.020 |
Why?
| | Treatment Outcome | 3 | 2015 | 9342 | 0.020 |
Why?
| | Complement C5 | 1 | 1989 | 75 | 0.020 |
Why?
| | Radionuclide Imaging | 2 | 1999 | 124 | 0.020 |
Why?
| | Predictive Value of Tests | 2 | 2007 | 1868 | 0.020 |
Why?
| | Exercise | 1 | 1998 | 1657 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1993 | 1171 | 0.020 |
Why?
| | Cattle | 1 | 1991 | 978 | 0.020 |
Why?
| | Neutropenia | 1 | 1988 | 133 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 1991 | 965 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1987 | 113 | 0.020 |
Why?
| | Hemodynamics | 2 | 1988 | 1004 | 0.020 |
Why?
| | United States | 1 | 2003 | 12555 | 0.020 |
Why?
| | Blood Pressure | 1 | 1993 | 1664 | 0.020 |
Why?
| | Animals | 5 | 1993 | 33381 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 1998 | 2220 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 1125 | 0.020 |
Why?
| | Survival Analysis | 1 | 2007 | 1267 | 0.020 |
Why?
| | Tidal Volume | 1 | 2004 | 74 | 0.010 |
Why?
| | Myocardium | 1 | 1988 | 970 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1991 | 4077 | 0.010 |
Why?
| | Factor VIII | 1 | 2003 | 56 | 0.010 |
Why?
| | Blood Coagulation Tests | 1 | 2003 | 58 | 0.010 |
Why?
| | Comorbidity | 1 | 2007 | 1527 | 0.010 |
Why?
| | Sex Factors | 1 | 2007 | 1781 | 0.010 |
Why?
| | Risk Factors | 2 | 2007 | 9000 | 0.010 |
Why?
| | Regression Analysis | 1 | 2004 | 983 | 0.010 |
Why?
| | Haplotypes | 1 | 2003 | 473 | 0.010 |
Why?
| | Kidney | 1 | 1988 | 1353 | 0.010 |
Why?
| | Child, Preschool | 1 | 1995 | 9491 | 0.010 |
Why?
| | Genome, Human | 1 | 2003 | 387 | 0.010 |
Why?
| | Age Factors | 1 | 2007 | 2995 | 0.010 |
Why?
| | False Negative Reactions | 1 | 1999 | 57 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2003 | 642 | 0.010 |
Why?
| | Iothalamate Meglumine | 1 | 1998 | 4 | 0.010 |
Why?
| | Technetium Tc 99m Aggregated Albumin | 1 | 1998 | 6 | 0.010 |
Why?
| | Iohexol | 1 | 1998 | 21 | 0.010 |
Why?
| | Critical Illness | 1 | 2004 | 662 | 0.010 |
Why?
| | Angiography, Digital Subtraction | 1 | 1998 | 46 | 0.010 |
Why?
| | Reference Standards | 1 | 1998 | 176 | 0.010 |
Why?
| | Colorado | 1 | 2007 | 4196 | 0.010 |
Why?
| | Angiography | 1 | 1998 | 185 | 0.010 |
Why?
| | Probability | 1 | 1998 | 305 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 1999 | 6561 | 0.010 |
Why?
| | Radiopharmaceuticals | 1 | 1998 | 194 | 0.010 |
Why?
| | Prospective Studies | 2 | 1999 | 6471 | 0.010 |
Why?
| | Veterans | 1 | 2007 | 1208 | 0.010 |
Why?
| | Adolescent | 1 | 1995 | 18480 | 0.010 |
Why?
| | Body Mass Index | 1 | 2004 | 2092 | 0.010 |
Why?
| | DNA | 1 | 2003 | 1388 | 0.010 |
Why?
| | Contrast Media | 1 | 1998 | 373 | 0.010 |
Why?
| | Child | 1 | 1995 | 19129 | 0.010 |
Why?
| | Acute Disease | 1 | 1998 | 940 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3171 | 0.010 |
Why?
| | Ultrasonography | 1 | 1999 | 716 | 0.010 |
Why?
| | Anticoagulants | 1 | 1999 | 559 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 709 | 0.010 |
Why?
| | Oxygenators | 1 | 1993 | 4 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1998 | 1795 | 0.010 |
Why?
| | Blood Vessels | 1 | 1993 | 187 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1999 | 2874 | 0.010 |
Why?
| | Complement System Proteins | 1 | 1993 | 294 | 0.010 |
Why?
| | Quinidine | 1 | 1987 | 6 | 0.000 |
Why?
| | Procainamide | 1 | 1987 | 5 | 0.000 |
Why?
| | Thiourea | 1 | 1987 | 38 | 0.000 |
Why?
| | Lidocaine | 1 | 1987 | 41 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1987 | 394 | 0.000 |
Why?
| | Organ Size | 1 | 1987 | 460 | 0.000 |
Why?
| | Hydrogen Peroxide | 1 | 1987 | 305 | 0.000 |
Why?
| | In Vitro Techniques | 1 | 1987 | 1094 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1999 | 12978 | 0.000 |
Why?
| | Rats | 1 | 1987 | 5392 | 0.000 |
Why?
|
|
Welsh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|